Objectively Measured Photoaging and Skin Cancer in Organ Transplant Recipients
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0417Keywords:
Solid organ transplant recipients, photoaging, photoaging phenotype, photodamage, actinic keratosis, keratinocyte skin cancerAbstract
Solid organ transplant recipients (SOTRs) have an increased risk of keratinocyte skin cancer (KC) due to lifelong immunosuppression. Photoaging, reflecting cumulative ultraviolet (UV) exposure, may serve as a biomarker of KC risk. This study characterized objective photoaging features in SOTRs and their association with age, photodamage, photoaging phenotype, actinic keratoses (AKs) and KC history. In 251 SOTRs, VISIA imaging showed significant age-related increases in photoaging features; median red- feature scores reflecting erythema and telangiectasia were 44 AU (arbitrary units) in patients >60 vs 22 AU in those <60. Higher clinical photodamage severity corresponded to higher VISIA scores, especially red- features and visible- spots. The atrophic photoaging phenotype, observed in 60 % of patients, showed higher red- features (40 AU) than the hypertrophic type (27 AU). Patients with AKs had elevated UV- spots and red- features. A history of KC (32 % of participants) was associated with older age, longer time since transplantation, fairer skin type, more severe photodamage, higher VISIA scores, especially red- features (45 AU vs 29 AU) and greater pigmentation on sun-exposed sites. Objective imaging identified photoaging features associated with cumulative UV damage. Further studies should evaluate their predictive value for KC development to improve individualized risk stratification and surveillance strategies in this high-risk population.
Downloads
References
Ferreira LD, Goff C, Kamepalli S, Montgomery AE, Miggins JJ, Goss JA, et al. Survival Benefit of Solid-Organ Transplantation: 10-Year Update. Dig Dis Sci 2023; 68: 3810–3817. DOI: https://doi.org/10.1007/s10620-023-08012-1
Kugler C, Gottlieb J, Warnecke G, Schwarz A, Weissenborn K, Barg-Hock H, et al. Health-related quality of life after solid organ transplantation: a prospective, multiorgan cohort study. Transplantation 2013; 96: 316–323. DOI: https://doi.org/10.1097/TP.0b013e31829853eb
Pilch NA, Bowman LJ, Taber DJ. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pharmacotherapy 2021; 41: 119–131. DOI: https://doi.org/10.1002/phar.2481
Krisl JC, Doan VP. Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients. Am J Transplant 2017; 17: 1974–1991. DOI: https://doi.org/10.1111/ajt.14238
Lee DS, Gigoyan L, Sells RE, Nugent JR, Goes NB, Harris HR, et al. Skin Cancer Surveillance Program for Solid Organ Transplant Recipients. JAMA Dermatol 2025; 161: 1238. DOI: https://doi.org/10.1001/jamadermatol.2025.3890
Shao EX, Betz-Stablein B, Khosrotehrani K, Campbell S, Isbel N, Green AC. Keratinocyte Cancer Mortality in Kidney Transplant Recipients. Transplantation 2022; 106: 1078–1083. DOI: https://doi.org/10.1097/TP.0000000000003827
Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681–1691. DOI: https://doi.org/10.1056/NEJMra022137
Gjersvik P. How to take the skin cancer risk of your transplant patient seriously. Transpl Int 2019; 32: 1244–1246. DOI: https://doi.org/10.1111/tri.13541
Crow LD, Jambusaria-Pahlajani A, Chung CL, Baran DA, Lowenstein SE, Abdelmalek M, et al. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. Transpl Int 2019; 32: 1268–1276. DOI: https://doi.org/10.1111/tri.13493
Gómez-Tomás Á, Bouwes Bavinck JN, Genders R, González-Cruz C, de Jong E, Arron S, et al. External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort. JAMA Dermatol 2023; 159: 29–36. DOI: https://doi.org/10.1001/jamadermatol.2022.4820
Sachs DL, Varani J, Chubb H, Fligiel SEG, Cui Y, Calderone K, et al. Atrophic and hypertrophic photoaging: Clinical, histologic, and molecular features of 2 distinct phenotypes of photoaged skin. J Am Acad Dermatol 2019; 81: 480–488. DOI: https://doi.org/10.1016/j.jaad.2019.03.081
Brooke RC, Newbold SA, Telfer NR, Griffiths CE. Discordance between facial wrinkling and the presence of basal cell carcinoma. Arch Dermatol 2001; 137: 751–754.
Pellacani G, Argenziano G. New insights from non-invasive imaging: from prospection of skin photodamages to training with mobile application. J Eur Acad Dermatol Venereol 2022; 36 Suppl 6: 38–50. DOI: https://doi.org/10.1111/jdv.18197
Oesch S, Vingan NR, Li X, Hoopman J, Akgul Y, Kenkel JM. A Correlation of the Glogau Scale With VISIA-CR Complexion Analysis Measurements in Assessing Facial Photoaging for Clinical Research. Aesthet Surg J 2022; 42: 1175–1184. DOI: https://doi.org/10.1093/asj/sjac108
Goldsberry A, Hanke CW, Hanke KE. VISIA system: a possible tool in the cosmetic practice. J Drugs Dermatol 2014; 13: 1312–1314.
Ly BCK, Dyer EB, Feig JL, Chien AL, Del Bino S. Research Techniques Made Simple: Cutaneous Colorimetry: A Reliable Technique for Objective Skin Color Measurement. J Invest Dermatol 2020; 140: 3–12. DOI: https://doi.org/10.1016/j.jid.2019.11.003
Pezzini C, Ciardo S, Guida S, Kaleci S, Chester J, Casari A, et al. Skin ageing: Clinical aspects and in vivo microscopic patterns observed with reflectance confocal microscopy and optical coherence tomography. Exp Dermatol 2023; 32: 348–358. DOI: https://doi.org/10.1111/exd.14708
Linming F, Wei H, Anqi L, Yuanyu C, Heng X, Sushmita P, et al. Comparison of two skin imaging analysis instruments: The VISIA® from Canfield vs the ANTERA 3D® CS from Miravex. Skin Res Technol 2018; 24: 3–8. DOI: https://doi.org/10.1111/srt.12381
Wenande E, Togsverd-Bo K, Hastrup A, Lei U, Philipsen PA, Haedersdal M. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study. Dermatology 2023; 239: 393–402. DOI: https://doi.org/10.1159/000529369
Park CK, Fung K, Austin PC, Kim SJ, Singer LG, Baxter NN, et al. Incidence and Risk Factors of Keratinocyte Carcinoma After First Solid Organ Transplant in Ontario, Canada. JAMA Dermatol 2019; 155: 1041–1048. DOI: https://doi.org/10.1001/jamadermatol.2019.0692
Additional Files
Published
How to Cite
License
Copyright (c) 2026 Stine R. Wiegell, Peter A. Philipsen, Susanne K. Kjær, Jay F. Nash, Peter Bjerring, Merete Hædersdal
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
